Zollinger-Ellison syndrome natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Zollinger-Ellison syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== ...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Zollinger-Ellison syndrome}}
{{Zollinger-Ellison syndrome}}
 
==Overview==
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
If left untreated, patients with Zollinger-Ellison syndrome may progress to develop [[abdominal pain]], [[diarrhea]], and [[heartburn]]<ref name="pmid11144036">{{cite journal| author=Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL et al.| title=Zollinger-Ellison syndrome. Clinical presentation in 261 patients. | journal=Medicine (Baltimore) | year= 2000 | volume= 79 | issue= 6 | pages= 379-411 | pmid=11144036 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11144036  }} </ref>. Common complications of Zollinger-Ellison syndrome include upper gastrointestinal [[bleeding]], [[anemia]], and [gastric ulcer perforation]. Prognosis is generally good, and the 5 and 10-year survival rate of patients with Zollinger-Ellison syndrome is approximately 94% and 75%, respectively.<ref name="pmid7903006">{{cite journal| author=Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC| title=Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. | journal=Surgery | year= 1993 | volume= 114 | issue= 6 | pages= 1183-8 | pmid=7903006 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7903006  }} </ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 10: Line 11:
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Syndromes]]
[[Category:Syndromes]]
[[Category:Needs content]]

Revision as of 13:21, 28 September 2015

Zollinger-Ellison syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Zollinger-Ellison syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zollinger-Ellison syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zollinger-Ellison syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zollinger-Ellison syndrome natural history, complications and prognosis

CDC on Zollinger-Ellison syndrome natural history, complications and prognosis

Zollinger-Ellison syndrome natural history, complications and prognosis in the news

Blogs on Zollinger-Ellison syndrome natural history, complications and prognosis

Directions to Hospitals Treating Zollinger-Ellison syndrome

Risk calculators and risk factors for Zollinger-Ellison syndrome natural history, complications and prognosis

Overview

If left untreated, patients with Zollinger-Ellison syndrome may progress to develop abdominal pain, diarrhea, and heartburn[1]. Common complications of Zollinger-Ellison syndrome include upper gastrointestinal bleeding, anemia, and [gastric ulcer perforation]. Prognosis is generally good, and the 5 and 10-year survival rate of patients with Zollinger-Ellison syndrome is approximately 94% and 75%, respectively.[2]

References

  1. Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL; et al. (2000). "Zollinger-Ellison syndrome. Clinical presentation in 261 patients". Medicine (Baltimore). 79 (6): 379–411. PMID 11144036.
  2. Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC (1993). "Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia". Surgery. 114 (6): 1183–8. PMID 7903006.

Template:WH Template:WS